Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (5): 1-6.doi: 10.6040/j.issn.1671-7554.0.2024.0121
• Precision medicine in chronic airway diseases—Expert Overview •
ZHANG Jintao, DONG Liang
CLC Number:
[1] Albrecht M, Garn H, Buhl T. Epithelial-immune cell interactions in allergic diseases[J]. Eur J Immunol, 2024, 54(1): e2249982. doi: 10.1002/eji.202249982. [2] Noureddine N, Chalubinski M, Wawrzyniak P. The role of defective epithelial barriers in allergic lung disease and asthma development[J]. J Asthma Allergy, 2022, 15: 487-504. doi: 10.2147/JAA.S324080. [3] Chen CY, Wu KH, Guo BC, et al. Personalized medicine in severe asthma: from biomarkers to biologics[J]. Int J Mol Sci, 2023, 25(1): 182. doi: 10.3390/ijms25010182. [4] Hellings PW, Steelant B. Epithelial barriers in allergy and asthma[J]. J Allergy Clin Immunol, 2020, 145(6): 1499-1509. [5] Vieira Braga FA, Kar G, Berg M, et al. A cellular census of human lungs identifies novel cell states in health and in asthma[J]. Nat Med, 2019, 25(7): 1153-1163. [6] Zhang N, Xu J, Jiang C, et al.Neuro-immune regulation in inflammation and airway remodeling of allergic asthma[J]. Front Immunol, 2022, 13: 894047. doi: 10.3389/fimmu.2022.894047. [7] Kohanski MA, Workman AD, Patel NN, et al. Solitary chemosensory cells are a primary epithelial source of IL-25 in patients with chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2018, 142(2): 460-469.e7. [8] Waghray A, Monga I, Lin B, et al. A deep lung cell atlas reveals cytokine-mediated lineage switching of a rare cell progenitor of the human airway epithelium[J]. bioRxiv, 2023. doi: 10.1101/2023.11.28.569028. [9] Gauvreau GM, Obyrne PM, Boulet LP, et al. Effects of an anti-TSLP antibody on allergen-induced asthmatic responses[J]. N Engl J Med, 2014, 370(22): 2102-2110. [10] Barlow JL, Peel S, Fox J, et al. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes(type 2 innate lymphoid cells)and airway contraction[J]. J Allergy Clin Immunol, 2013, 132(4): 933-941. [11] Duchesne M, Okoye I, Lacy P. Epithelial cell alarmin cytokines: frontline mediators of the asthma inflammatory response[J]. Front Immunol, 2022, 13: 975914. doi: 10.3389/fimmu.2022.975914. [12] Liu T, Liu Y, Miller M, et al. Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma[J]. Am J Physiol Lung Cell Mol Physiol, 2017, 313(1): L27-L40. [13] Zhang J, Zhang D, Pan Y, et al. The TL1A-DR3 axis in asthma: membrane-bound and secreted TL1A co-determined the development of airway remodeling[J]. Allergy Asthma Immunol Res, 2022, 14(2): 233-253. [14] Liu F, Zhang J, Zhang D, et al. Follistatin-related protein 1 in asthma: miR-200b-3p interactions affect airway remodeling and inflammation phenotype[J]. Int Immunopharmacol, 2022, 109: 108793. doi: 10.1016/j.intimp.2022.108793. [15] Guo Z, Wu J, Zhao J, et al. IL-33 promotes airway remodeling and is a marker of asthma disease severity[J]. J Asthma, 2014, 51(8): 863-869. [16] Cao L, Liu F, Liu Y, et al. TSLP promotes asthmatic airway remodeling via p38-STAT3 signaling pathway in human lung fibroblast[J]. Exp Lung Res, 2018, 44(6): 288-301. [17] Zhang J, Dong L. Status and prospects: personalized treatment and biomarker for airway remodeling in asthma[J]. J Thorac Dis, 2020, 12(10): 6090-6101. [18] Andreasson LM, Dyhre-Petersen N, Hvidtfeldt M, et al. Airway hyperresponsiveness correlates with airway TSLP in asthma independent of eosinophilic inflammation[J]. J Allergy Clin Immunol, 2023: S0091-6749(23)02409-0. doi: 10.1016/j.jaci.2023.11.915. [19] Chatziparasidis G, Bush A, Chatziparasidi MR, et al. Airway epithelial development and function: a key player in asthma pathogenesis?[J]. Paediatr Respir Rev, 2023, 47: 51-61. doi: 10.1016/j.prrv.2023.04.005. [20] Frey A, Lunding LP, Ehlers JC, et al. More than just a barrier: the immune functions of the airway epithelium in asthma pathogenesis[J]. Front Immunol, 2020, 11: 761. doi: 10.3389/fimmu.2020.00761. [21] Basil MC, Katzen J, Engler AE, et al. The cellular and physiological basis for lung repair and regeneration: past, present, and future[J]. Cell Stem Cell, 2020, 26(4): 482-502. [22] Basil MC, Cardenas-Diaz FL, Kathiriya JJ, et al. Human distal airways contain a multipotent secretory cell that can regenerate alveoli[J]. Nature, 2022, 604(7904): 120-126. [23] Smolinska S, Antolín-Amérigo D, Popescu FD, et al. Thymic stromal lymphopoietin(TSLP), its isoforms and the interplay with the epithelium in allergy and asthma[J]. Int J Mol Sci, 2023, 24(16): 12725. doi: 10.3390/ijms241612725. [24] Chen W, Chen S, Yan C, et al. Allergen protease-activated stress granule assembly and gasdermin D fragmentation control interleukin-33 secretion[J]. Nat Immunol, 2022, 23(7): 1021-1030. [25] Zhang D, Zhang J, Xu C, et al. A humanized mouse model to study asthmatic airway remodeling and Muc-5ac secretion via the human IL-33[J]. Allergy, 2024. 79(5): 1364-1367. [26] Qi Q, Xu J, Wang Y, et al. Decreased sphingosine due to down-regulation of acid ceramidase expression in airway of bronchiectasis patients: a potential contributor to pseudomonas aeruginosa infection[J]. Infect Drug Resist, 2023, 16: 2573-2588. doi: 10.2147/IDR.S407335. [27] Saikumar Jayalatha AK, Jonker MR, Carpaij OA, et al. Lack of a transcriptional response of primary bronchial epithelial cells from patients with asthma and controls to IL-33[J]. Am J Physiol Lung Cell Mol Physiol, 2024, 326(1): L65-L70. [28] Ruhl A, Antão AV, Dietschmann A, et al. STAT6-induced production of mucus and resistin-like molecules in lung Club cells does not protect against helminth or influenza A virus infection[J]. Eur J Immunol, 2024, 54(1): e2350558. doi: 10.1002/eji.202350558. [29] Li Y, Zhang Q, Li L, et al. LKB1 deficiency upregulates RELM-α to drive airway goblet cell metaplasia[J]. Cell Mol Life Sci, 2021, 79(1): 42. doi: 10.1007/s00018-021-04044-w. [30] Kortekaas RK, Geillinger-Kästle KE, Borghuis T, et al. Interleukin-11 disrupts alveolar epithelial progenitor function[J]. ERJ Open Res, 2023, 9(3): 00679-2022. doi: 10.1183/23120541.00679-2022. [31] Thomas D, Mcdonald VM, Pavord ID, et al. Asthma remission: what is it and how can it be achieved?[J]. Eur Respir J, 2022, 60(5): 2102583. doi: 10.1183/13993003.02583-2021. [32] Mümmler C, Milger K. Biologics for severe asthma and beyond[J]. Pharmacol Ther, 2023, 252: 108551. doi: 10.1016/j.pharmthera.2023.108551. [33] Chan R, Stewart K, Misirovs R, et al. Targeting downstream type 2 cytokines or upstream epithelial alarmins for severe asthma[J]. J Allergy Clin Immunol Pract, 2022, 10(6): 1497-1505. [34] Shinkai M, Yabuta T. Tezepelumab: an anti-thymic stromal lymphopoietin monoclonal antibody for the treatment of asthma[J]. Immunotherapy, 2023, 15(17): 1435-1447. [35] Wechsler ME, Ruddy MK, Pavord ID, et al. Efficacy and safety of itepekimab in patients with moderate-to-severe asthma[J]. N Engl J Med, 2021, 385(18): 1656-1668. [36] Maspero J, Agache IO, Kamei T, et al. Long-term safety and exploratory efficacy of fevipiprant in patients with inadequately controlled asthma: the SPIRIT randomised clinical trial[J]. Respir Res, 2021, 22(1): 311. doi: 10.1186/s12931-021-01904-8. [37] Eger K, Kroes JA, Ten Brinke A, et al. Long-term therapy response to anti-IL-5 biologics in severe asthma-a real-life evaluation[J]. J Allergy Clin Immunol Pract, 2021, 9(3): 1194-1200. [38] Demarche SF, Schleich FN, Paulus VA, et al. Is it possible to claim or refute sputum eosinophils ≥ 3% in asthmatics with sufficient accuracy using biomarkers?[J]. Respir Res, 2017, 18(1): 133. doi: 10.1186/s12931-017-0615-9. [39] Gautam S, Chu JH, Cohen AJ, et al. Sputum alarmins delineate distinct T2 cytokine pathways and unique subtypes of patients with asthma[J]. Allergy, 2023, 78(12): 3274-3277. [40] Banno A, Reddy AT, Lakshmi SP, et al. Bidirectional interaction of airway epithelial remodeling and inflammation in asthma[J]. Clin Sci(Lond), 2020, 134(9): 1063-1079. [41] Vannella KM, Ramalingam TR, Borthwick LA, et al. Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine-driven inflammation and fibrosis[J]. Sci Transl Med, 2016, 8(337): 337ra65. doi: 10.1126/scitranslmed.aaf1938. |
[1] | BU Meiling, WANG Jinrong, FENG Mei, SUN Lifeng. Mechanism of FOXM1 in acute exacerbation of asthma induced by respiratory virus infection in mice [J]. Journal of Shandong University (Health Sciences), 2023, 61(6): 1-9. |
[2] | LI Huayu, SHI Xiaohan, ZHANG Xinrui, LI Feng. Association between sleep disturbance and inflammatory cytokines in 203 patients with glioma [J]. Journal of Shandong University (Health Sciences), 2022, 60(12): 26-30. |
[3] | ZHANG Weiwei, HUA Fang, LIANG Chaoshuai, CHU Miaomiao, SUN Jiayi, FRANK Zaucke, XIN Wei. Thyroid stimulating hormone promotes chondrocyte differentiation via anti-inflammatory protein CTRP3 [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 1-8. |
[4] | GE Shaohua, DING Tian, LIU Hongrui. Role and regulatory mechanism of type 2 immunity in tissue repair [J]. Journal of Shandong University (Health Sciences), 2021, 59(9): 51-56. |
[5] | ZHANG Qian, QIN Mingming, HE Xuejia, CAI Qiujing, ZHANG Yamin, LI Qingsu, ZHU Weiwei. Effects of calcitriol on EMT induced by TGF-β1 in asthma [J]. Journal of Shandong University (Health Sciences), 2021, 59(7): 10-18. |
[6] | LI Xiangqing, YIN Xin, ZHAO Xuelian, ZHAO Peiqing. Expression and clinical significance of circulating CD56bright subset of NK cells in patients with Parkinsons disease [J]. Journal of Shandong University (Health Sciences), 2021, 59(2): 34-40. |
[7] | LIU Xiaofei, LIANG Ying, ZHANG Congxi, WANG Juan, PAN Yun, XU Jiawei, CHANG Chun, DONG Liang. Association of serum leptin with induced sputum eosinophils in 92 asthmatic patients [J]. Journal of Shandong University (Health Sciences), 2020, 1(9): 27-33. |
[8] | CAI Qiujing, ZHANG Qian, HE Xuejia, SUN Wenli, GUO Aili, ZHANG Nan, ZHU Weiwei. Airway smooth muscle cells regulate IL-33 expression through TGF-β1/Smad3 signaling pathway to participate in asthma [J]. Journal of Shandong University (Health Sciences), 2020, 58(4): 78-83. |
[9] | YANG Liping, MU Tingting, YANG Yujuan, ZHANG Yu, SONG Xicheng. Effects of inhaled allergens on pulmonary function in children with adenoid hypertrophy complicated with bronchial asthma [J]. Journal of Shandong University (Health Sciences), 2020, 58(3): 107-112. |
[10] | LI Yan, NIU Rui, WANG Chaochao. Analysis of the bronchodilator test of 122 patients with asthma [J]. Journal of Shandong University (Health Sciences), 2020, 58(11): 81-84. |
[11] | WANG Haixia, LI Yizhang, BAI Chenxiao, JIANG Di, WANG Liwen, CHEN Ou. A Meta-analysis of the efficacy and safety of clarithromycin in adjuvant treatment of asthma [J]. Journal of Shandong University (Health Sciences), 2019, 57(11): 27-33. |
[12] | CHEN Ou, LI Guoyong, LIU Aihong, ZHU Xiaobo, CHEN Shaojie, WANG Yibiao. Anti-inflammatory mechanism of ephedra treatment of asthma based on network pharmacology [J]. Journal of Shandong University (Health Sciences), 2019, 57(1): 55-61. |
[13] | GONG Xiaodan, ZHAO Fangzheng, CAO Ke, DENG Penghui, ZHANG Caiqing. Effect of myosin light chain kinase on airway inflammation and lung function in asthma model mice [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 18-23. |
[14] | LIU Xiaojuan, DING Lijie, KANG Fengling, ZHOU Miao, XUE Fuzhong. A prediction model for bronchial asthma risk based on a health management population [J]. Journal of Shandong University (Health Sciences), 2017, 55(12): 56-61. |
[15] | LIU Qingfa, WANG Chao, SUN Qijing, GONG Xiaodan, ZHANG Caiqing. Effect of interleukin-25 on inducing the airway remodeling of asthma mice by nuocyte cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(8): 28-33. |
|